ArticleDigital health
Genetic Algorithm-Optimized support vector machine for MRI-based multiple sclerosis diagnosis from white matter lesion features.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates a genetic algorithm-assisted support vector machine (GA-SVM) framework for multiple sclerosis (MS) diagnosis using a publicly available dataset (n=709; 370 MS, 339 controls) comprising five pre-extracted white matter lesion features. Model performance was assessed using repeated nested stratified 10×5 cross-validation, with hyperparameter optimization confined to inner training folds and results reported from aggregated out-of-fold predictions. The tuned RBF-SVM achieved AUC=0.993, accuracy=0.987, sensitivity=1.000, specificity=0.973, precision=0.976, and F1-score=0.988 at a probability threshold of 0.5. Precision-recall (AP≈0.99) and calibration analysis (Brier=0.012) confirmed strong discrimination and reliable probability estimates. Comparative benchmarking showed competitive performance while preserving model simplicity and interpretability. These findings support the feasibility of compact radiomics combined with rigorously validated classical machine learning for MS classification. External multi-site validation is required to confirm generalizability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.